Financhill
Sell
48

OXY Quote, Financials, Valuation and Earnings

Last price:
$49.30
Seasonality move :
7.78%
Day range:
$48.61 - $49.36
52-week range:
$44.70 - $71.19
Dividend yield:
1.83%
P/E ratio:
20.16x
P/S ratio:
1.78x
P/B ratio:
1.79x
Volume:
5.9M
Avg. volume:
12.4M
1-year change:
-25.9%
Market cap:
$46.2B
Revenue:
$26.7B
EPS (TTM):
$2.44
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $17.8B $26B $36.6B $28.3B $26.7B
Revenue Growth (YoY) -14.83% 45.75% 41.14% -22.87% -5.42%
 
Cost of Revenues $16.6B $18.1B $19B $18.1B $17.2B
Gross Profit $1.2B $7.9B $17.6B $10.1B $9.6B
Gross Profit Margin 6.99% 30.24% 48.17% 35.78% 35.73%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $864M $863M $945M $1.1B $1.1B
Other Inc / (Exp) -$13.1B $488M $1.3B $821M -$519M
Operating Expenses $2.5B $3.2B $4B $3.7B $4B
Operating Income -$1.3B $4.7B $13.7B $6.4B $5.6B
 
Net Interest Expenses $1.3B $1.4B $877M $806M $1B
EBT. Incl. Unusual Items -$15.7B $3.7B $14.1B $6.4B $4.1B
Earnings of Discontinued Ops. -$1.3B -$468M -- -- $182M
Income Tax Expense -$2.2B $915M $813M $1.7B $1.2B
Net Income to Company -$14.8B $2.3B $13.3B $4.7B $3.1B
 
Minority Interest in Earnings -- -- -- -- -$22M
Net Income to Common Excl Extra Items -$14.8B $2.3B $13.3B $4.7B $3.1B
 
Basic EPS (Cont. Ops) -$17.06 $1.62 $13.41 $4.22 $2.59
Diluted EPS (Cont. Ops) -$17.06 $1.58 $12.40 $3.90 $2.44
Weighted Average Basic Share $918.7M $935M $926.2M $889.2M $911.8M
Weighted Average Diluted Share $918.7M $958.8M $1B $960.9M $967.1M
 
EBITDA -$6.2B $13.8B $22.1B $14.2B $12.6B
EBIT -$14.3B $5.3B $15.1B $7.4B $5.2B
 
Revenue (Reported) $17.8B $26B $36.6B $28.3B $26.7B
Operating Income (Reported) -$1.3B $4.7B $13.7B $6.4B $5.6B
Operating Income (Adjusted) -$14.3B $5.3B $15.1B $7.4B $5.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $4.2B $7.9B $8.2B $7.2B $6.8B
Revenue Growth (YoY) -37.24% 90.22% 3.87% -12.74% -5.75%
 
Cost of Revenues $3.8B $4.6B $4.8B $4.8B $4.4B
Gross Profit $316M $3.3B $3.5B $2.4B $2.3B
Gross Profit Margin 7.6% 41.6% 42.17% 33.66% 34.29%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $209M $280M $258M $307M $276M
Other Inc / (Exp) -$629M $514M $261M $442M -$1.1B
Operating Expenses $733M $952M $1.1B $1.1B $1.1B
Operating Income -$417M $2.3B $2.4B $1.3B $1.2B
 
Net Interest Expenses $379M $361M $229M $215M $286M
EBT. Incl. Unusual Items -$1.4B $2.5B $2.4B $1.6B -$169M
Earnings of Discontinued Ops. $37M -$24M -- -- --
Income Tax Expense -$276M $469M $473M $361M -$49M
Net Income to Company -$1.1B $1.5B $1.9B $1.2B -$120M
 
Minority Interest in Earnings -- -- -- -- -$7M
Net Income to Common Excl Extra Items -$1.1B $1.5B $1.9B $1.2B -$127M
 
Basic EPS (Cont. Ops) -$1.41 $1.42 $1.90 $1.16 -$0.32
Diluted EPS (Cont. Ops) -$1.41 $1.37 $1.74 $1.08 -$0.32
Weighted Average Basic Share $933.1M $936.8M $905.8M $881.1M $940.9M
Weighted Average Diluted Share $933.1M $972.6M $990.3M $950.4M $984.2M
 
EBITDA $738M $4.8B $4.5B $3.5B $2.1B
EBIT -$1B $2.9B $2.7B $1.8B $158M
 
Revenue (Reported) $4.2B $7.9B $8.2B $7.2B $6.8B
Operating Income (Reported) -$417M $2.3B $2.4B $1.3B $1.2B
Operating Income (Adjusted) -$1B $2.9B $2.7B $1.8B $158M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $17.8B $26B $36.6B $28.3B $26.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $16.6B $18.1B $19B $18.1B $17.2B
Gross Profit $1.2B $7.9B $17.6B $10.1B $9.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $864M $863M $945M $1.1B $1.1B
Other Inc / (Exp) -$13.2B $488M $1.3B $821M -$519M
Operating Expenses $2.5B $3.2B $4B $3.7B $4B
Operating Income -$1.3B $4.7B $13.7B $6.4B $5.6B
 
Net Interest Expenses $1.3B $1.4B $877M $806M $1B
EBT. Incl. Unusual Items -$15.8B $3.7B $14.1B $6.4B $4.1B
Earnings of Discontinued Ops. -$1.3B -$468M -- -- $182M
Income Tax Expense -$2.2B $915M $813M $1.7B $1.2B
Net Income to Company -$14.8B $2.3B $13.3B $4.7B $3.1B
 
Minority Interest in Earnings -- -- -- -- -$22M
Net Income to Common Excl Extra Items -$14.8B $2.3B $13.3B $4.7B $3.1B
 
Basic EPS (Cont. Ops) -$17.09 $1.62 $13.36 $4.22 $2.62
Diluted EPS (Cont. Ops) -$17.09 $1.55 $12.38 $3.91 $2.44
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$6.2B $13.8B $22.1B $14.2B $12.6B
EBIT -$14.3B $5.3B $15.1B $7.4B $5.2B
 
Revenue (Reported) $17.8B $26B $36.6B $28.3B $26.7B
Operating Income (Reported) -$1.3B $4.7B $13.7B $6.4B $5.6B
Operating Income (Adjusted) -$14.3B $5.3B $15.1B $7.4B $5.2B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $26B $36.6B $28.3B $26.7B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $18.1B $19B $18.1B $17.2B --
Gross Profit $7.9B $17.6B $10.1B $9.6B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $863M $945M $1.1B $1.1B --
Other Inc / (Exp) $488M $1.3B $821M -$519M --
Operating Expenses $3.2B $4B $3.7B $4B --
Operating Income $4.7B $13.7B $6.4B $5.6B --
 
Net Interest Expenses $1.4B $877M $806M $1B --
EBT. Incl. Unusual Items $3.7B $14.1B $6.4B $4.1B --
Earnings of Discontinued Ops. -$468M -- -- $182M --
Income Tax Expense $915M $813M $1.7B $1.2B --
Net Income to Company $2.3B $13.3B $4.7B $3.1B --
 
Minority Interest in Earnings -- -- -- -$22M --
Net Income to Common Excl Extra Items $2.3B $13.3B $4.7B $3.1B --
 
Basic EPS (Cont. Ops) $1.62 $13.36 $4.22 $2.62 --
Diluted EPS (Cont. Ops) $1.55 $12.38 $3.91 $2.44 --
Weighted Average Basic Share $3.7B $3.7B $3.6B $3.6B --
Weighted Average Diluted Share $3.8B $4B $3.8B $3.9B --
 
EBITDA $13.8B $22.1B $14.2B $12.6B --
EBIT $5.3B $15.1B $7.4B $5.2B --
 
Revenue (Reported) $26B $36.6B $28.3B $26.7B --
Operating Income (Reported) $4.7B $13.7B $6.4B $5.6B --
Operating Income (Adjusted) $5.3B $15.1B $7.4B $5.2B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2B $2.8B $984M $1.4B $2.1B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.1B $4.2B $4.3B $3.2B $3.5B
Inventory $1.9B $1.8B $2.1B $2B $2.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.2B $1.4B $1.6B $830M $597M
Total Current Assets $8.8B $10.2B $8.9B $8.4B $9.1B
 
Property Plant And Equipment $67B $60.7B $59.3B $59.7B $70.3B
Long-Term Investments $3.3B $2.9B $3.2B $3.2B $3.2B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1B $1.2B $1.3B $2.8B $2.9B
Total Assets $80.1B $75B $72.6B $74B $85.4B
 
Accounts Payable $3B $3.9B $4B $3.6B $3.8B
Accrued Expenses $3.6B $4.1B $3.3B $1B $1.1B
Current Portion Of Long-Term Debt $398M $101M $22M $1.1B $1B
Current Portion Of Capital Lease Obligations $515M $271M $416M $592M $509M
Other Current Liabilities $753M -- -- $1.4B $1.1B
Total Current Liabilities $8.2B $8.3B $7.8B $9.1B $9.5B
 
Long-Term Debt $35.4B $28.9B $19.1B $17.9B $24.3B
Capital Leases -- -- -- -- --
Total Liabilities $61.5B $54.7B $42.5B $43.7B $51B
 
Common Stock $10B $10B $10B $8.5B $8.5B
Other Common Equity Adj -$288M -$208M $195M $275M $179M
Common Equity $8.8B $10.6B $20.3B $22B $25.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $99M $321M
Total Equity $18.6B $20.3B $30.1B $30.3B $34.5B
 
Total Liabilities and Equity $80.1B $75B $72.6B $74B $85.4B
Cash and Short Terms $2B $2.8B $984M $1.4B $2.1B
Total Debt $35.8B $29B $19.1B $19B $25.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2B $2.8B $984M $1.4B $2.1B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.1B $4.2B $4.3B $3.2B $3.5B
Inventory $1.9B $1.8B $2.1B $2B $2.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.2B $1.4B $1.6B $830M $597M
Total Current Assets $8.8B $10.2B $8.9B $8.4B $9.1B
 
Property Plant And Equipment $67B $60.7B $59.3B $59.7B $70.3B
Long-Term Investments $3.3B $2.9B $3.2B $3.2B $3.2B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1B $1.2B $1.3B $2.8B $2.9B
Total Assets $80.1B $75B $72.6B $74B $85.4B
 
Accounts Payable $3B $3.9B $4B $3.6B $3.8B
Accrued Expenses $3.6B $4.1B $3.3B $1B $1.1B
Current Portion Of Long-Term Debt $398M $101M $22M $1.1B $1B
Current Portion Of Capital Lease Obligations $515M $271M $416M $592M $509M
Other Current Liabilities $753M -- -- $1.4B $1.1B
Total Current Liabilities $8.2B $8.3B $7.8B $9.1B $9.5B
 
Long-Term Debt $35.4B $28.9B $19.1B $17.9B $24.3B
Capital Leases -- -- -- -- --
Total Liabilities $61.5B $54.7B $42.5B $43.7B $51B
 
Common Stock $10B $10B $10B $8.5B $8.5B
Other Common Equity Adj -$288M -$208M $195M $275M $179M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $99M $321M
Total Equity $18.6B $20.3B $30.1B $30.3B $34.5B
 
Total Liabilities and Equity $80.1B $75B $72.6B $74B $85.4B
Cash and Short Terms $2B $2.8B $984M $1.4B $2.1B
Total Debt $35.8B $29B $19.1B $19B $25.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$14.8B $2.3B $13.3B $4.7B $3.1B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $2.1B -$2.1B -$432M $1.1B $170M
Change in Inventories -$484M -$86M -$230M -$91M -$46M
Cash From Operations $4B $10.4B $16.8B $12.3B $11.4B
 
Capital Expenditures $3.1B $2.9B $4.5B $6.3B $7B
Cash Acquisitions -$5M $406M -$116M -$470M -$212M
Cash From Investing -$819M -$1.3B -$4.9B -$7B -$14.6B
 
Dividends Paid (Ex Special Dividend) -$1.8B -$839M -$1.2B -$1.4B -$1.4B
Special Dividend Paid
Long-Term Debt Issued $6.9B -- $400M $900M $9.6B
Long-Term Debt Repaid -$8.9B -$6.8B -$9.9B -$968M -$4.5B
Repurchase of Common Stock -$12M -$8M -$3.1B -$3.5B -$27M
Other Financing Activities -$805M -$914M -$241M -$133M -$365M
Cash From Financing -$4.5B -$8.6B -$13.7B -$4.9B $3.8B
 
Beginning Cash (CF) $3.6B $2.2B $2.8B $1B $1.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.4B $609M -$1.8B $438M $693M
Ending Cash (CF) $2.2B $2.8B $1B $1.5B $2.2B
 
Levered Free Cash Flow $901M $7.6B $12.3B $6B $4.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$1.1B $1.5B $1.9B $1.2B -$120M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.2B -$720M -$570M $466M $702M
Change in Inventories -$242M -$178M -$134M -$47M $180M
Cash From Operations $1.4B $3.1B $4B $3.2B $3.4B
 
Capital Expenditures $408M $937M $1.5B $1.5B $1.8B
Cash Acquisitions -$91M $549M $445M -$48M -$63M
Cash From Investing $1.6B -$51M -$1.9B -$2B -$1.8B
 
Dividends Paid (Ex Special Dividend) -$211M -$209M -$321M -$330M -$377M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2B -- -- -- --
Long-Term Debt Repaid -$4.3B -$2.3B -$1.2B -$46M -$507M
Repurchase of Common Stock -$12M -$8M -$632M -$187M -$18M
Other Financing Activities -$325M -$42M -$220M $65M -$313M
Cash From Financing -$2.9B -$2.5B -$2.3B -$455M -$1.2B
 
Beginning Cash (CF) $2.1B $2.3B $1.3B $649M $1.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $120M $509M -$253M $815M $364M
Ending Cash (CF) $2.2B $2.8B $1B $1.5B $2.2B
 
Levered Free Cash Flow $996M $2.2B $2.5B $1.7B $1.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$14.8B $2.3B $13.3B $4.7B $3.1B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $2.1B -$2.1B -$432M $1.1B $170M
Change in Inventories -$484M -$86M -$230M -$91M -$46M
Cash From Operations $4B $10.4B $16.8B $12.3B $11.4B
 
Capital Expenditures $3.1B $2.9B $4.5B $6.3B $7B
Cash Acquisitions -$5M $406M -$116M -$470M -$212M
Cash From Investing -$819M -$1.3B -$4.9B -$7B -$14.6B
 
Dividends Paid (Ex Special Dividend) -$1.8B -$839M -$1.2B -$1.4B -$1.4B
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$8.9B -$6.8B -$9.9B -$968M -$4.5B
Repurchase of Common Stock -- -$8M -$3.1B -$3.5B -$27M
Other Financing Activities -$805M -$914M -$241M -$133M -$365M
Cash From Financing -$4.5B -$8.6B -$13.7B -$4.9B $3.8B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.4B $609M -$1.8B $438M $693M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $901M $7.6B $12.3B $6B $4.4B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $2.3B $13.3B $4.7B $3.1B --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.1B -$432M $1.1B $170M --
Change in Inventories -$86M -$230M -$91M -$46M --
Cash From Operations $10.4B $16.8B $12.3B $11.4B --
 
Capital Expenditures $2.9B $4.5B $6.3B $7B --
Cash Acquisitions $406M -$116M -$470M -$212M --
Cash From Investing -$1.3B -$4.9B -$7B -$14.6B --
 
Dividends Paid (Ex Special Dividend) -$839M -$1.2B -$1.4B -$1.4B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $400M $900M $9.6B --
Long-Term Debt Repaid -$6.8B -$9.9B -$968M -$4.5B --
Repurchase of Common Stock -$8M -$3.1B -$3.5B -$27M --
Other Financing Activities -$914M -$241M -$133M -$365M --
Cash From Financing -$8.6B -$13.7B -$4.9B $3.8B --
 
Beginning Cash (CF) $11.7B $7.4B $3.4B $6.5B --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $609M -$1.8B $438M $693M --
Ending Cash (CF) $12.3B $5.7B $3.9B $7.2B --
 
Levered Free Cash Flow $7.6B $12.3B $6B $4.4B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Should I Buy Alcoa Stock?
Should I Buy Alcoa Stock?

Alcoa (AA) finds itself in an interesting position in early…

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
52
NUTX alert for Apr 2

Nutex Health [NUTX] is up 5.41% over the past day.

Buy
52
PVH alert for Apr 2

PVH [PVH] is up 1.81% over the past day.

Sell
15
PCVX alert for Apr 2

Vaxcyte [PCVX] is up 4.47% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock